Literature DB >> 11096025

Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment.

M Radisic1, A Torn, P Gutierrez, H A Defranchi, P Pardo.   

Abstract

Published evidence of pathogenetic mechanisms of acute respiratory distress syndrome (ARDS) in mycoplasmal lung infections suggests that the pulmonary injury is related to a cell-mediated immune response. Therefore, steroids may play a role in the treatment of severe cases. We describe a patient who had Mycoplasma pneumoniae pneumonia that progressed to severe ARDS requiring mechanical ventilation and who had improvement with prednisolone pulses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096025     DOI: 10.1086/317498

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

1.  Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection.

Authors:  M Narita; H Tanaka; S Yamada; S Abe; T Ariga; Y Sakiyama
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report.

Authors:  Naoki Takahashi; Tsutomu Shinohara; Rie Oi; Muneyuki Ota; Shinichi Toriumi; Fumitaka Ogushi
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 3.  Imaging of community-acquired pneumonia: Roles of imaging examinations, imaging diagnosis of specific pathogens and discrimination from noninfectious diseases.

Authors:  Atsushi Nambu; Katsura Ozawa; Noriko Kobayashi; Masao Tago
Journal:  World J Radiol       Date:  2014-10-28

4.  Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Authors:  Monica Fonseca-Aten; Christine M Salvatore; Asunción Mejías; Ana M Ríos; Susana Chávez-Bueno; Kathy Katz; Ana M Gómez; George H McCracken; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

Review 6.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia.

Authors:  You-Sook Youn; Kyung-Yil Lee; Ja-Young Hwang; Jung-Woo Rhim; Jin-Han Kang; Joon-Sung Lee; Ji-Chang Kim
Journal:  BMC Pediatr       Date:  2010-07-06       Impact factor: 2.125

8.  Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia.

Authors:  Daisuke Kurai; Kazuhide Nakagaki; Hiroo Wada; Takeshi Saraya; Shigeru Kamiya; Yasunori Fujioka; Koh Nakata; Hajime Takizawa; Hajime Goto
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.

Authors:  C Tagliabue; C M Salvatore; C Techasaensiri; A Mejias; J P Torres; K Katz; A M Gomez; S Esposito; N Principi; R D Hardy
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003.

Authors:  Jinho Yu; Young Yoo; Do Kyun Kim; Hee Kang; Young Yull Koh
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.